Tobramycin and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Tobramycin (tobramycin), especially for people who are female, 60+ old, also take Sucralfate, and have Back pain.

The phase IV clinical study analyzes which people have Blindness when taking Tobramycin. It is created by eHealthMe based on reports of 3,545 people who have side effects when taking Tobramycin from the FDA, and is updated regularly.

What is Tobramycin?

Tobramycin has active ingredients of tobramycin. It is often used in cystic fibrosis. eHealthMe is studying from 3,579 Tobramycin users. Check the latest studies of Tobramycin.

What is Blindness?

Blindness is found to be associated with 1,508 drugs and 1,990 conditions by eHealthMe. Check the latest studies of Blindness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 04, 2026

3,545 people reported to have side effects when taking Tobramycin.
Among them, 14 people (0.39%) have Blindness.

Among these 14 people:

What is the gender of people who have Blindness when taking Tobramycin? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Blindness when taking Tobramycin? *

What are other drugs people take besides Tobramycin? *

Sucralfate: 4 people, 28.57%
Ofloxacin: 3 people, 21.43%
Elmiron: 3 people, 21.43%
Vancomycin: 3 people, 21.43%
Esomeprazole Magnesium: 3 people, 21.43%
Lantus: 2 people, 14.29%
Dexamethasone: 2 people, 14.29%
Morphine: 2 people, 14.29%
Clonidine: 2 people, 14.29%
Ceftazidime: 2 people, 14.29%

What are other side effects people have besides Blindness? *

Stress And Anxiety: 3 people, 21.43%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 3 people, 21.43%
Visual Impairment: 3 people, 21.43%
Eye Pain: 3 people, 21.43%
Depression: 3 people, 21.43%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 14.29%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 2 people, 14.29%
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest): 2 people, 14.29%
Retinal Exudates (discharge from retina): 2 people, 14.29%
Eye Infection: 2 people, 14.29%

What are the existing conditions these people have? *

Gastric Ulcer (stomach ulcer): 3 people, 21.43%
Ear Disorder: 3 people, 21.43%
Cystitis Interstitial (unknown cause characterized by bladder pain): 3 people, 21.43%
Back Pain: 3 people, 21.43%
Intervertebral Disc Protrusion (spinal disc protrusion): 2 people, 14.29%
Conjunctivitis (pink eye): 2 people, 14.29%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 1 person, 7.14%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 7.14%
Infection: 1 person, 7.14%
Endophthalmitis (inflammation of the internal coats of the eye): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tobramycin and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tobramycin:

Tobramycin (3,579 reports)

Blindness treatments and more:

Blindness (45,948 reports)

Browse all side effects of Tobramycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Blindness (1,508 drugs)

Browse all the conditions that are associated with Blindness:

Blindness (1,990 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin (the active ingredients of Tobramycin) and Tobramycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.